Inhibition of P450 17 as a New Strategy for the Treatment of Prostate Cancer

By  

Current Medicinal Chemistry, Vol. 12, Iss. 14, 2005-07 ,pp. : 1623-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Enzyme Sources on Midazolam 1-Hydroxylation Activity Catalyzed by Recombinant Cytochrome P450 3A4 in Combination with NADPH-Cytochrome P450 Reductase

By  

Drug Metabolism Letters, Vol. 2, Iss. 3, 2008-08 ,pp. : 190-192

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of multiple cytochrome P450 activities in metabolically inactivated human liver microsomes and roles of P450 2C isoforms in reaction phenotyping studies

By  

Biopharmaceutics And Drug Disposition, Vol. 39, Iss. 2, 2018-02 ,pp. : 116-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis, Biochemical Evaluation and Rationalisation of the Inhibitory Activity of a Range of Derivatives of 2-imidazol-1-yl-1-phenyl-ethanone as Potential Novel Inhibitors of 17-hydroxylase/17,20-lyase (P-45017)

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 6, 2011-07 ,pp. : 516-522

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biochemical Evaluation of a Range of 2-, 3- and 4-Substituted Derivatives of Benzyl Imidazole-Based Compounds as Probes of the Active Site of 17#945;-hydroxylase/17,20-Lyase (P45017#945;)

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 7, 2009-10 ,pp. : 524-530

Bentham Science Publishers

Access to resources Recommend Favorite